June 7, 2022
Asep Medical Holdings Inc. Receives Revocation of Cease Trade Order from the BC Securities Commission.
April 26, 2022
Asep Medical Holdings Inc. Announces Additional Listing to the OTCQB Venture Market in the U.S.
March 22, 2022
Asep Medical Holdings Inc. Announces Compelling Results of an Independent Sepsis Study Prepared by RTI Health Solutions
March 3, 2022
Asep Medical Holdings Inc. to Hold Online Investor Information Webinar on March 3, 2022
February 19, 2022
Asep Medical Inc. Announces its Antibiofilm/Anti-inflammatory Peptide Technology is in Advanced Development for Wound Dressings with US Army Funding1
February 2, 2022
Asep Medical Holdings Inc. Announces an Exclusive Licensing Arrangement for a Patented and Novel AI-Driven Sepsis Diagnosis Technology Developed at the University of British Columbia (UBC)
January 25, 2022